D2R awards $10 million to accelerate RNA-based therapies for rare diseases and cancer

Published: 26 March 2025

Montreal, March 26, 2025 – McGill University’s DNA to RNA Initiative (D2R) has awarded over $10 million in funding to support three groundbreaking research projects that will advance RNA-based...

Investment In a Quebec Public-Private Partnership to Support the Use of Personalized Medicine Solutions in the Treatment of Cancer Patients

Published: 21 February 2013

The Government of Québec announced today a $10 million investment in the Personalized Medicine Partnership for Cancer (PMPC). This public-private partnership will be focused on establishing an...

Back to top